491 related articles for article (PubMed ID: 18294500)
1. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial.
Underhill HR; Yuan C; Zhao XQ; Kraiss LW; Parker DL; Saam T; Chu B; Takaya N; Liu F; Polissar NL; Neradilek B; Raichlen JS; Cain VA; Waterton JC; Hamar W; Hatsukami TS
Am Heart J; 2008 Mar; 155(3):584.e1-8. PubMed ID: 18294500
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
[TBL] [Abstract][Full Text] [Related]
3. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging.
Corti R; Fuster V; Fayad ZA; Worthley SG; Helft G; Chaplin WF; Muntwyler J; Viles-Gonzalez JF; Weinberger J; Smith DA; Mizsei G; Badimon JJ
J Am Coll Cardiol; 2005 Jul; 46(1):106-12. PubMed ID: 15992643
[TBL] [Abstract][Full Text] [Related]
4. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
Catapano AL; Davidson MH; Ballantyne CM; Brady WE; Gazzara RA; Tomassini JE; Tershakovec AM
Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
[TBL] [Abstract][Full Text] [Related]
5. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Davidson MH
Clin Ther; 2007 Nov; 29(11):2385-94. PubMed ID: 18158079
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
[TBL] [Abstract][Full Text] [Related]
7. Early decrease in carotid plaque lipid content as assessed by magnetic resonance imaging during treatment of rosuvastatin.
Du R; Cai J; Zhao XQ; Wang QJ; Liu DQ; Leng WX; Gao P; Wu HM; Ma L; Ye P
BMC Cardiovasc Disord; 2014 Jul; 14():83. PubMed ID: 25022285
[TBL] [Abstract][Full Text] [Related]
8. One-year treatment with rosuvastatin reduces intima-media thickness in 45 hypercholesterolemic subjects with asymptomatic carotid artery disease.
Riccioni G; Vitulano N; Mancini B; Zanasi A; D'Orazio N
Pharmacology; 2010; 85(2):63-7. PubMed ID: 20110750
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study).
Ballantyne CM; Weiss R; Moccetti T; Vogt A; Eber B; Sosef F; Duffield E;
Am J Cardiol; 2007 Mar; 99(5):673-80. PubMed ID: 17317370
[TBL] [Abstract][Full Text] [Related]
10. Tracking regression and progression of atherosclerosis in human carotid arteries using high-resolution magnetic resonance imaging.
Adams GJ; Greene J; Vick GW; Harrist R; Kimball KT; Karmonik C; Ballantyne CM; Insull W; Morrisett JD
Magn Reson Imaging; 2004 Nov; 22(9):1249-58. PubMed ID: 15607096
[TBL] [Abstract][Full Text] [Related]
11. Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting.
Fox KM; Gandhi SK; Ohsfeldt RL; Davidson MH
Am J Manag Care; 2007 Dec; 13 Suppl 10():S270-5. PubMed ID: 18095777
[TBL] [Abstract][Full Text] [Related]
12. Comparison of effectiveness of rosuvastatin versus atorvastatin on the achievement of combined C-reactive protein (<2 mg/L) and low-density lipoprotein cholesterol (< 70 mg/dl) targets in patients with type 2 diabetes mellitus (from the ANDROMEDA study).
Betteridge DJ; Gibson JM; Sager PT
Am J Cardiol; 2007 Oct; 100(8):1245-8. PubMed ID: 17920365
[TBL] [Abstract][Full Text] [Related]
13. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy.
Lima JA; Desai MY; Steen H; Warren WP; Gautam S; Lai S
Circulation; 2004 Oct; 110(16):2336-41. PubMed ID: 15477398
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia.
Lamendola C; Abbasi F; Chu JW; Hutchinson H; Cain V; Leary E; McLaughlin T; Stein E; Reaven G
Am J Cardiol; 2005 Jan; 95(2):189-93. PubMed ID: 15642550
[TBL] [Abstract][Full Text] [Related]
15. Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol.
Bergheanu SC; Van Tol A; Dallinga-Thie GM; Liem A; Dunselman PH; Van der Bom JG; Jukema JW
Curr Med Res Opin; 2007 Sep; 23(9):2235-40. PubMed ID: 17692153
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia.
Avis HJ; Hutten BA; Gagné C; Langslet G; McCrindle BW; Wiegman A; Hsia J; Kastelein JJ; Stein EA
J Am Coll Cardiol; 2010 Mar; 55(11):1121-6. PubMed ID: 20223367
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients.
van der Lee M; Sankatsing R; Schippers E; Vogel M; Fätkenheuer G; van der Ven A; Kroon F; Rockstroh J; Wyen C; Bäumer A; de Groot E; Koopmans P; Stroes E; Reiss P; Burger D
Antivir Ther; 2007; 12(7):1127-32. PubMed ID: 18018771
[TBL] [Abstract][Full Text] [Related]
18. Monday, Wednesday, and Friday dosing of rosuvastatin in patients previously intolerant to statin therapy.
Mackie BD; Satija S; Nell C; Miller J; Sperling LS
Am J Cardiol; 2007 Jan; 99(2):291. PubMed ID: 17223437
[TBL] [Abstract][Full Text] [Related]
19. Impact of a compliance program on cholesterol control: results of the randomized ORBITAL study in 8108 patients treated with rosuvastatin.
Willich SN; Englert H; Sonntag F; Völler H; Meyer-Sabellek W; Wegscheider K; Windler E; Katus H; Müller-Nordhorn J
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):180-7. PubMed ID: 19174696
[TBL] [Abstract][Full Text] [Related]
20. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI.
Yonemura A; Momiyama Y; Fayad ZA; Ayaori M; Ohmori R; Kihara T; Tanaka N; Nakaya K; Ogura M; Taniguchi H; Kusuhara M; Nagata M; Nakamura H; Tamai S; Ohsuzu F
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):222-8. PubMed ID: 19242355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
